IDEAS home Printed from https://ideas.repec.org/r/aea/aecrev/v87y1997i1p222-30.html
   My bibliography  Save this item

Disease Eradication: Private versus Public Vaccination

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Rikard Forslid & Mathias Herzing, 2015. "On the Optimal Production Capacity for Influenza Vaccine," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, June.
  2. Cerdeiro, Diego A., 2017. "Contagion exposure and protection technology," Games and Economic Behavior, Elsevier, vol. 105(C), pages 230-254.
  3. Marlène Guillon & Josselin Thuilliez, 2015. "HIV and Rational risky behaviors: a systematic review of published empirical literature (1990-2013)," Post-Print halshs-01222571, HAL.
  4. Chris T Bauch & Samit Bhattacharyya, 2012. "Evolutionary Game Theory and Social Learning Can Determine How Vaccine Scares Unfold," PLOS Computational Biology, Public Library of Science, vol. 8(4), pages 1-12, April.
  5. d’Albis, Hippolyte & Augeraud-Véron, Emmanuelle, 2021. "Optimal prevention and elimination of infectious diseases," Journal of Mathematical Economics, Elsevier, vol. 93(C).
  6. Costello, Christopher & Quérou, Nicolas & Tomini, Agnes, 2017. "Private eradication of mobile public bads," European Economic Review, Elsevier, vol. 94(C), pages 23-44.
  7. Andrea Galeotti & Brian W. Rogers, 2013. "Strategic Immunization and Group Structure," American Economic Journal: Microeconomics, American Economic Association, vol. 5(2), pages 1-32, May.
  8. Doriana Delfino & Peter J. Simmons, "undated". "Infectious Disease Control by Vaccines Giving Full or Partial Immunity," Discussion Papers 99/32, Department of Economics, University of York.
  9. Matteo M. Galizzi & Krystal W. Lau & Marisa Miraldo & Katharina Hauck, 2022. "Bandwagoning, free‐riding and heterogeneity in influenza vaccine decisions: An online experiment," Health Economics, John Wiley & Sons, Ltd., vol. 31(4), pages 614-646, April.
  10. Ranjan, Ram, 2007. "Technology Adoption Against Invasive Species," Journal of Agricultural and Applied Economics, Southern Agricultural Economics Association, vol. 39(Special), pages 1-14, October.
  11. Edwin Michael & Mwele N Malecela & Mihail Zervos & James W Kazura, 2008. "Global Eradication of Lymphatic Filariasis: The Value of Chronic Disease Control in Parasite Elimination Programmes," PLOS ONE, Public Library of Science, vol. 3(8), pages 1-9, August.
  12. Robert Nuscheler & Kerstin Roeder, 2016. "To Vaccinate or to Procrastinate? That is the Prevention Question," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1560-1581, December.
  13. Thuilliez, Josselin & Touré, Nouhoum, 2024. "Opinions and vaccination during an epidemic," Journal of Mathematical Economics, Elsevier, vol. 111(C).
  14. Casey Mulligan & Tomas Philipson, "undated". "Merit Motives and Government Intervention: Public Finance in Reverse," University of Chicago - Population Research Center 2000-03, Chicago - Population Research Center.
  15. van Ackere, Ann & Schulz, Peter J., 2020. "Explaining vaccination decisions: A system dynamics model of the interaction between epidemiological and behavioural factors," Socio-Economic Planning Sciences, Elsevier, vol. 71(C).
  16. David E. Bloom & Michael Kuhn & Klaus Prettner, 2022. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
  17. David A. Hennessy, 2007. "Behavioral Incentives, Equilibrium Endemic Disease, and Health Management Policy for Farmed Animals," American Journal of Agricultural Economics, Agricultural and Applied Economics Association, vol. 89(3), pages 698-711.
  18. Barrett, Scott & Hoel, Michael, 2007. "Optimal disease eradication," Environment and Development Economics, Cambridge University Press, vol. 12(5), pages 627-652, October.
  19. Blondel, Serge & Langot, François & Mueller, Judith E. & Sicsic, Jonathan, 2021. "Preferences and COVID-19 Vaccination Intentions," IZA Discussion Papers 14823, Institute of Labor Economics (IZA).
  20. Marette, Stéphan & Roe, Brian E. & Teisl, Mario, 2012. "The welfare impact of food pathogen vaccines," Food Policy, Elsevier, vol. 37(1), pages 86-93.
  21. David Bardey & Giancarlo Buitrago, 2015. "Integración vertical en el sector de la salud colombiano," Documentos CEDE 14069, Universidad de los Andes, Facultad de Economía, CEDE.
  22. Marion Davin & Mouez Fodha & Thomas Seegmuller, 2023. "Environment, public debt, and epidemics," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 25(6), pages 1270-1303, December.
  23. Xinyan Shi, 2013. "Information disclosure and vaccination externalities," International Journal of Economic Theory, The International Society for Economic Theory, vol. 9(3), pages 229-243, September.
  24. Snyder, Christopher M. & Hoyt, Kendall & Gouglas, Dimitrios, 2023. "An optimal mechanism to fund the development of vaccines against emerging epidemics," Journal of Health Economics, Elsevier, vol. 91(C).
  25. Francesca Barigozzi, 2004. "Reimbursing Preventive Care," The Geneva Papers on Risk and Insurance Theory, Springer;International Association for the Study of Insurance Economics (The Geneva Association), vol. 29(2), pages 165-186, December.
  26. Kairiza, Terrence & Kembo, George & Chigusiwa, Lloyd, 2023. "Herding behavior in COVID-19 vaccine hesitancy in rural Zimbabwe: The moderating role of health information under heterogeneous household risk perceptions," Social Science & Medicine, Elsevier, vol. 323(C).
  27. Troy Tassier & Philip Polgreen & Alberto Segre, 2017. "Network position and health care worker infections," Journal of Economic Interaction and Coordination, Springer;Society for Economic Science with Heterogeneous Interacting Agents, vol. 12(2), pages 277-307, July.
  28. Kessing, Sebastian G. & Nuscheler, Robert, 2006. "Monopoly pricing with negative network effects: The case of vaccines," European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
  29. Auld, M. Christopher & Toxvaerd, Flavio, 2021. "The Great Covid-19 Vaccine Rollout: Behavioural And Policy Responses," National Institute Economic Review, National Institute of Economic and Social Research, vol. 257, pages 14-35, August.
  30. Marion Davin & Mouez Fodha & Thomas Seegmuller, 2021. "Environment, public debt and epidemics," AMSE Working Papers 2128, Aix-Marseille School of Economics, France.
  31. Alexander E. Saak & David A. Hennessy, 2018. "A model of reporting and controlling outbreaks by public health agencies," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 66(1), pages 21-64, July.
  32. Matan J. Cohen & Mayer Brezis & Colin Block & Adele Diederich & David Chinitz, 2013. "Vaccination, Herd Behavior, and Herd Immunity," Medical Decision Making, , vol. 33(8), pages 1026-1038, November.
  33. Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 40(2), pages 468-492, May.
  34. Sadique, Z. & Edmunds, W. J. & Devlin, N. & Parkin, D., 2005. "Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models," Working Papers 05/03, Department of Economics, City University London.
  35. Wang, Tong, 2012. "Essays on the Economics of Disease, with Particular Reference to Livestock," ISU General Staff Papers 201201010800003982, Iowa State University, Department of Economics.
  36. Acemoglu, Daron & Malekian, Azarakhsh & Ozdaglar, Asu, 2016. "Network security and contagion," Journal of Economic Theory, Elsevier, vol. 166(C), pages 536-585.
  37. Goyal, Sanjeev & Vigier, Adrien, 2015. "Interaction, protection and epidemics," Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
  38. Cécile Aubert & Emmanuelle Augeraud-Véron, 2021. "The relative power of individual distancing efforts and public policies to curb the COVID-19 epidemics," PLOS ONE, Public Library of Science, vol. 16(5), pages 1-21, May.
  39. Chanel, Olivier & Luchini, Stéphane & Massoni, Sébastien & Vergnaud, Jean-Christophe, 2011. "Impact of information on intentions to vaccinate in a potential epidemic: Swine-origin Influenza A (H1N1)," Social Science & Medicine, Elsevier, vol. 72(2), pages 142-148, January.
  40. Azomahou, Theophile & Diene, Bity & Soete, Luc, 2009. "The role of consumption and the financing of health investment under epidemic shocks," MERIT Working Papers 2009-006, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  41. Manuel Hoffmann & Roberto Mosquera & Adrian Chadi, 2019. "Vaccines at Work," TWI Research Paper Series 116, Thurgauer Wirtschaftsinstitut, Universität Konstanz.
  42. Krishna Dasaratha, 2020. "Virus Dynamics with Behavioral Responses," Papers 2004.14533, arXiv.org, revised Sep 2023.
  43. Oster, Emily, 2018. "Does disease cause vaccination? Disease outbreaks and vaccination response," Journal of Health Economics, Elsevier, vol. 57(C), pages 90-101.
  44. Sanjeev Goyal & Adrien Vigier, 2014. "Attack, Defence, and Contagion in Networks," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 81(4), pages 1518-1542.
  45. Kimberly M. Thompson & Nima D. Badizadegan, 2017. "Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases," Risk Analysis, John Wiley & Sons, vol. 37(6), pages 1109-1131, June.
  46. Ranjan, Ram & Evans, Edward A., 2007. "Private Responses to Public Incentives for Invasive Species Management," Farm and Business - The Journal of the Caribbean Agro-Economic Society, Caribbean Agro-Economic Society, vol. 7(1), pages 1-24.
  47. Troy Tassier & Philip Polgreen & Alberto Segre, 2015. "Vaccination Games with Peer Effects in a Heterogeneous Hospital Worker Population," Administrative Sciences, MDPI, vol. 5(1), pages 1-25, January.
  48. Sarkar, Jayanta, 2022. "Do disease prevalence and severity drive COVID-19 vaccine demand?," Economic Analysis and Policy, Elsevier, vol. 75(C), pages 310-319.
  49. Radboud J. Duintjer Tebbens & Kimberly M. Thompson, 2009. "Priority Shifting and the Dynamics of Managing Eradicable Infectious Diseases," Management Science, INFORMS, vol. 55(4), pages 650-663, April.
  50. Josselin Thuilliez & Nouhoum Touré, 2024. "Opinions and vaccination during an epidemic," Post-Print hal-04490900, HAL.
  51. Matthew O. Jackson & Brian W. Rogers & Yves Zenou, 2017. "The Economic Consequences of Social-Network Structure," Journal of Economic Literature, American Economic Association, vol. 55(1), pages 49-95, March.
  52. Xu, Xiaopeng, 1999. "Technological improvements in vaccine efficacy and individual incentive to vaccinate," Economics Letters, Elsevier, vol. 65(3), pages 359-364, December.
  53. repec:hal:wpaper:halshs-01222571 is not listed on IDEAS
  54. Corey White, 2021. "Measuring Social and Externality Benefits of Influenza Vaccination," Journal of Human Resources, University of Wisconsin Press, vol. 56(3), pages 749-785.
  55. Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
  56. David Crainich & Louis Eeckhoudt & Mario Menegatti, 2019. "Vaccination as a trade-off between risks," Italian Economic Journal: A Continuation of Rivista Italiana degli Economisti and Giornale degli Economisti, Springer;Società Italiana degli Economisti (Italian Economic Association), vol. 5(3), pages 455-472, October.
  57. Tong Wang & David A. Hennessy, 2015. "Strategic Interactions Among Private and Public Efforts When Preventing and Stamping Out a Highly Infectious Animal Disease," American Journal of Agricultural Economics, Agricultural and Applied Economics Association, vol. 97(2), pages 435-451.
  58. Courtney J. Ward, 2009. "Influenza Immunization Campaigns: Is an Ounce of Prevention Worth a Pound of Cure?," Working Papers daleconwp2010-01, Dalhousie University, Department of Economics.
  59. Tomas J. Philipson & Gary S. Becker, 1998. "Old-Age Longevity and Mortality-Contingent Claims," Journal of Political Economy, University of Chicago Press, vol. 106(3), pages 551-573, June.
  60. Anna K. Lugnér & Sido D. Mylius & Jacco Wallinga, 2010. "Dynamic versus static models in cost‐effectiveness analyses of anti‐viral drug therapy to mitigate an influenza pandemic," Health Economics, John Wiley & Sons, Ltd., vol. 19(5), pages 518-531, May.
  61. Elisa Sicuri & David B Evans & Fabrizio Tediosi, 2015. "Can Economic Analysis Contribute to Disease Elimination and Eradication? A Systematic Review," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-21, June.
  62. Adida, Elodie & Dey, Debabrata & Mamani, Hamed, 2013. "Operational issues and network effects in vaccine markets," European Journal of Operational Research, Elsevier, vol. 231(2), pages 414-427.
  63. Wisarut Suwanprasert, 2020. "COVID-19 and Endogenous Public Avoidance: Insights from an Economic Model," PIER Discussion Papers 128, Puey Ungphakorn Institute for Economic Research.
  64. Wataru Kureishi, 2009. "Partial vaccination programs and the eradication of infectious diseases," Economics Bulletin, AccessEcon, vol. 29(4), pages 2758-2769.
  65. Daniel L. Bennett & Boris Nikolaev, 2021. "Historical Disease Prevalence, Cultural Values, and Global Innovation," Entrepreneurship Theory and Practice, , vol. 45(1), pages 145-174, January.
  66. Albert, Jason, 2021. "Strategic dynamics of antibiotic use and the evolution of antibiotic-resistant infections," International Journal of Industrial Organization, Elsevier, vol. 77(C).
  67. Amy Finkelstein, 2003. "Health Policy and Technological Change: Evidence from the Vaccine Industry," NBER Working Papers 9460, National Bureau of Economic Research, Inc.
  68. Sims, Charles & Finnoff, David & O’Regan, Suzanne M., 2016. "Public control of rational and unpredictable epidemics," Journal of Economic Behavior & Organization, Elsevier, vol. 132(PB), pages 161-176.
  69. Hirani, Jonas Cuzulan & Wüst, Miriam, 2022. "Nurses and infant vaccination coverage," Journal of Economic Behavior & Organization, Elsevier, vol. 196(C), pages 402-428.
  70. Dasaratha, Krishna, 2023. "Virus dynamics with behavioral responses," Journal of Economic Theory, Elsevier, vol. 214(C).
  71. Andrew Souther & Myong-Hun Chang & Troy Tassier, 2023. "It’s worth a shot: urban density, endogenous vaccination decisions, and dynamics of infectious disease," Journal of Economic Interaction and Coordination, Springer;Society for Economic Science with Heterogeneous Interacting Agents, vol. 18(1), pages 163-189, January.
  72. Charles Shaw & Silvio Vanadia, 2022. "Utilitarianism on the front lines: COVID-19, public ethics, and the "hidden assumption" problem," Papers 2205.01957, arXiv.org.
  73. Federico, Salvatore & Ferrari, Giorgio & Torrente, Maria-Laura, 2022. "Optimal Vaccination in a SIRS Epidemic Model," Center for Mathematical Economics Working Papers 667, Center for Mathematical Economics, Bielefeld University.
  74. Boni, Maciej F. & Galvani, Alison P. & Wickelgren, Abraham L. & Malani, Anup, 2013. "Economic epidemiology of avian influenza on smallholder poultry farms," Theoretical Population Biology, Elsevier, vol. 90(C), pages 135-144.
  75. Wooyoung Lim & Pengfei Zhang, 2020. "Herd immunity and a vaccination game: An experimental study," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-16, May.
  76. Cronin, Christopher J. & Evans, William N., 2021. "Total shutdowns, targeted restrictions, or individual responsibility: How to promote social distancing in the COVID-19 Era?," Journal of Health Economics, Elsevier, vol. 79(C).
  77. Radboud J. Duintjer Tebbens & Kimberly M. Thompson, 2018. "Using integrated modeling to support the global eradication of vaccine‐preventable diseases," System Dynamics Review, System Dynamics Society, vol. 34(1-2), pages 78-120, January.
  78. Barham, Tania & Maluccio, John A., 2009. "Eradicating diseases: The effect of conditional cash transfers on vaccination coverage in rural Nicaragua," Journal of Health Economics, Elsevier, vol. 28(3), pages 611-621, May.
  79. Courtney J. Ward, 2014. "Influenza Vaccination Campaigns: Is an Ounce of Prevention Worth a Pound of Cure?," American Economic Journal: Applied Economics, American Economic Association, vol. 6(1), pages 38-72, January.
  80. Na Hao & Gervan Fearon, 2009. "Government Funding Policy Towards Communicable Diseases," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(2), pages 121-134, June.
  81. Sanjeev Goyal & Adrien Vigier, 2014. "Attack, Defence, and Contagion in Networks," Review of Economic Studies, Oxford University Press, vol. 81(4), pages 1518-1542.
  82. Casey B. Mulligan, 2021. "The Backward Art of Slowing the Spread? Congregation Efficiencies during COVID-19," NBER Working Papers 28737, National Bureau of Economic Research, Inc.
  83. Soya Miyoshi & Marko Jusup & Petter Holme, 2021. "Flexible imitation suppresses epidemics through better vaccination," Journal of Computational Social Science, Springer, vol. 4(2), pages 709-720, November.
  84. Laurent Coudeville, 2003. "Measles dynamics and vaccination diffusion," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 4(4), pages 319-326, December.
  85. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).
  86. repec:esx:essedp:707 is not listed on IDEAS
  87. Simon Binder & Robert Nuscheler, 2017. "Risk‐taking in vaccination, surgery, and gambling environments: Evidence from a framed laboratory experiment," Health Economics, John Wiley & Sons, Ltd., vol. 26(S3), pages 76-96, December.
  88. Christopher J. Cronin & William N. Evans, 2020. "Private Precaution and Public Restrictions: What Drives Social Distancing and Industry Foot Traffic in the COVID-19 Era?," NBER Working Papers 27531, National Bureau of Economic Research, Inc.
  89. Skatun, John Douglas, 2003. "The overprovision of infectious disease medicine," Economics Letters, Elsevier, vol. 80(1), pages 61-66, July.
  90. Scott Barrett, 2007. "The Smallpox Eradication Game," Public Choice, Springer, vol. 130(1), pages 179-207, January.
  91. Neilson, William & Xiao, Yancheng, 2018. "Equilibrium vaccination patterns in incomplete and heterogeneous networks," European Economic Review, Elsevier, vol. 105(C), pages 174-192.
  92. Shiv Dixit, 2023. "Contract Enforcement and Preventive Healthcare: Theory and Evidence," Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 51, pages 1048-1094, December.
  93. Hirani, Jonas Lau-Jensen, 2021. "Inattention or reluctance? Parental responses to vaccination reminder letters," Journal of Health Economics, Elsevier, vol. 76(C).
  94. Sykes, David & Rychtář, Jan, 2015. "A game-theoretic approach to valuating toxoplasmosis vaccination strategies," Theoretical Population Biology, Elsevier, vol. 105(C), pages 33-38.
  95. Casey B. Mulligan, 2021. "Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation," NBER Working Papers 29574, National Bureau of Economic Research, Inc.
  96. Berry, Kevin & Finnoff, David & Horan, Richard D. & Shogren, Jason F., 2015. "Managing the endogenous risk of disease outbreaks with non-constant background risk," Journal of Economic Dynamics and Control, Elsevier, vol. 51(C), pages 166-179.
  97. Mulligan, Casey B. & Philipson, Tomas J., 2000. "Merit Motives & Government Intervention: Public Finance in Reverse," Working Papers 159, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  98. Glenn L. Furton, 2023. "The pox of politics: Troesken’s tradeoff reexamined," Public Choice, Springer, vol. 195(1), pages 169-191, April.
  99. John C. Eckalbar & Pete Tsournos & Walter L. Eckalbar, 2015. "Dynamics In An Sir Model When Vaccination Demand Follows Prior Levels Of Disease Prevalence," Advances in Complex Systems (ACS), World Scientific Publishing Co. Pte. Ltd., vol. 18(07n08), pages 1-27, November.
  100. Telalagic, S., 2012. "Optimal Treatment of an SIS Disease with Two Strains," Cambridge Working Papers in Economics 1229, Faculty of Economics, University of Cambridge.
  101. Josselin Thuilliez & Nouhoum Touré, 2024. "Opinions and vaccination during an epidemic," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-04490900, HAL.
  102. Andrew Abel & Stavros Panageas, 2024. "Are Zero-Covid Policies Optimal?," Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 53, pages 47-70, July.
  103. Sabine Liebenehm & Bernard Bett & Cristobal Verdugo & Mohamed Said, 2016. "Optimal Drug Control under Risk of Drug Resistance – The Case of African Animal Trypanosomosis," Journal of Agricultural Economics, Wiley Blackwell, vol. 67(2), pages 510-533, June.
  104. Xu, Danni & Wang, Fan & Zhuo, Xiaopo & Liu, Yaoqi, 2024. "The performance of government subsidy schemes in a competitive vaccine market considering consumers' free-riding behavior," International Journal of Production Economics, Elsevier, vol. 268(C).
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.